Artisan Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-117,345
Closed -$19.2M 316
2022
Q1
$19.2M Sell
117,345
-121,791
-51% -$19.9M 0.03% 285
2021
Q4
$40.6M Sell
239,136
-3,648
-2% -$619K 0.05% 256
2021
Q3
$45.8M Buy
242,784
+4,202
+2% +$793K 0.06% 246
2021
Q2
$40.4M Buy
238,582
+10,394
+5% +$1.76M 0.05% 257
2021
Q1
$32.2M Buy
228,188
+28,015
+14% +$3.96M 0.04% 272
2020
Q4
$26M Buy
200,173
+36,481
+22% +$4.74M 0.03% 268
2020
Q3
$23.8M Buy
163,692
+36,867
+29% +$5.37M 0.03% 260
2020
Q2
$18.8M Buy
126,825
+20,599
+19% +$3.05M 0.03% 263
2020
Q1
$11.6M Buy
+106,226
New +$11.6M 0.02% 257
2016
Q4
Sell
-221,733
Closed -$15M 260
2016
Q3
$15M Sell
221,733
-3,470
-2% -$235K 0.03% 231
2016
Q2
$12.5M Sell
225,203
-8,456
-4% -$469K 0.03% 230
2016
Q1
$14.7M Sell
233,659
-4,364
-2% -$274K 0.03% 235
2015
Q4
$22.4M Sell
238,023
-6,881
-3% -$648K 0.04% 217
2015
Q3
$19.7M Sell
244,904
-774,376
-76% -$62.2M 0.04% 221
2015
Q2
$122M Sell
1,019,280
-65,280
-6% -$7.83M 0.23% 136
2015
Q1
$113M Buy
1,084,560
+793,178
+272% +$82.8M 0.2% 142
2014
Q4
$28.3M Sell
291,382
-256,474
-47% -$24.9M 0.05% 233
2014
Q3
$42.8M Sell
547,856
-27,002
-5% -$2.11M 0.08% 201
2014
Q2
$36.3M Buy
574,858
+55,975
+11% +$3.54M 0.06% 230
2014
Q1
$34.8M Buy
518,883
+75,161
+17% +$5.05M 0.06% 235
2013
Q4
$28.5M Buy
443,722
+20,899
+5% +$1.34M 0.05% 242
2013
Q3
$27.1M Buy
+422,823
New +$27.1M 0.05% 250